Whole-genome characterization of Candidozyma auris isolates from a Korean tertiary care centre: clade II predominance, partly unexplained fluconazole resistance and a clade I isolate
- 1Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea
- 2Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
- 3Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
Abstract
In South Korea, Candidozyma auris is dominated by ear-associated clade II isolates, but institution-based genomic data remain limited. We analysed 35 archived isolates from 29 patients at a tertiary care centre between 2017 and 2023 using antifungal susceptibility testing and whole-genome sequencing. Thirty-four isolates belonged to clade II, and one urine isolate recovered after inter-hospital transfer belonged to subclade Ib. Serial clade II isolates from the same patient clustered together and had lower pairwise SNP distances than different-patient pairs (median, 8.5 versus 181). Among the first isolates from 29 patients, 14 (48.3%) were fluconazole resistant. In first clade II isolates, recurrent curated coding variation was concentrated in TAC1B and ERG11; TAC1B F214S and W198C and ERG11 K143R occurred only in resistant isolates, but recognized coding variants did not account for all resistant isolates. Clade II isolates shared a broadly conserved subtelomeric deletion backbone, with variable chromosome 6 loss of selected glycosylphosphatidylinositol-anchor genes. The clade Ib isolate carried ERG11 Y132F, TAC1B A583S and a CDR1 V704L/E709D-like change and met CDC tentative breakpoints for resistance to fluconazole, amphotericin B and caspofungin. These findings refine the genomic profile of Korean clade II isolates and highlight the potential introduction of a distinct clade I lineage through healthcare transfer.
Related
- Clinical correlates for fluconazole resistance in Candida bloodstream infections.
- SLA1 governs azole resistance in Candidozyma auris via mitochondrial ROS-driven efflux pump expression
- Predominance of SCCmec type III, multidrug resistance, and evidence of ica-independent biofilm formation among clinical Staphylococcus aureus isolates in Riyadh, Saudi Arabia
- The catheterized urinary tract selects for MRR1-mediated efflux and fluconazole resistance in Candida albicans biofilms
- Predominance of autoimmune heparin-induced thrombocytopenia in a nephrology department
BibTeX
@article{park2026wholegenome,
title = {{Whole-genome characterization of Candidozyma auris isolates from a Korean tertiary care centre: clade II predominance, partly unexplained fluconazole resistance and a clade I isolate}},
author = {Jae Hyeon Park and Jee-Soo Lee and Seung Won Chae and Taek Soo Kim and Moon-Woo Seong},
journal = {Microbial Genomics},
year = {2026},
month = nov,
doi = {10.1099/mgen.0.001802},
url = {https://doi.org/10.1099/mgen.0.001802},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Whole-genome characterization of Candidozyma auris isolates from a Korean tertiary care centre: clade II predominance, partly unexplained fluconazole resistance and a clade I isolate
AU - Jae Hyeon Park
AU - Jee-Soo Lee
AU - Seung Won Chae
AU - Taek Soo Kim
AU - Moon-Woo Seong
PY - 2026
DA - 2026/11/03
JO - Microbial Genomics
DO - 10.1099/mgen.0.001802
UR - https://doi.org/10.1099/mgen.0.001802
AB - In South Korea, Candidozyma auris is dominated by ear-associated clade II isolates, but institution-based genomic data remain limited. We analysed 35 archived isolates from 29 patients at a tertiary care centre between 2017 and 2023 using antifungal susceptibility testing and whole-genome sequencing. Thirty-four isolates belonged to clade II, and one urine isolate recovered after inter-hospital transfer belonged to subclade Ib. Serial clade II isolates from the same patient clustered together and had lower pairwise SNP distances than different-patient pairs (median, 8.5 versus 181). Among the first isolates from 29 patients, 14 (48.3%) were fluconazole resistant. In first clade II isolates, recurrent curated coding variation was concentrated in TAC1B and ERG11; TAC1B F214S and W198C and ERG11 K143R occurred only in resistant isolates, but recognized coding variants did not account for all resistant isolates. Clade II isolates shared a broadly conserved subtelomeric deletion backbone, with variable chromosome 6 loss of selected glycosylphosphatidylinositol-anchor genes. The clade Ib isolate carried ERG11 Y132F, TAC1B A583S and a CDR1 V704L/E709D-like change and met CDC tentative breakpoints for resistance to fluconazole, amphotericin B and caspofungin. These findings refine the genomic profile of Korean clade II isolates and highlight the potential introduction of a distinct clade I lineage through healthcare transfer.
SN - 2057-5858
ER -